Expression of VEGF and Its significance in primary diffuse large B-cell lymphoma of the female genital system

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 1, 2009, Pages 48-51

  Tang, Qiong Lan ^a   Jiang, Xue Feng ^a   Yang, Kai Xuan ^a   Li, Hai Gang ^a   Liu, Wei Ping ^a   Peng, Zhi Lan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Large cell, diffuse; Lymphoma; Prognosis; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; FEMALE; FEMALE GENITAL TRACT TUMOR; GENETICS; HUMAN; LARGE CELL LYMPHOMA; METABOLISM; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PROGNOSIS; UTERINE CERVIX TUMOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 59449095009     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Chinese source
2. Chinese source
3. Chinese source
4. Chinese source
5. Traina TA, Rugo HS, Diekler M, et al. Bevaeizumab for advanced breast cancer. Hematol Oncol Clin North, 2007; 21(2): 303-319.
6. Gratzinger D, Zhao S, Tibshirani RJ, et al. Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. Lab Invest, 2008; 88(1): 38-47.
7. Gratzinger D, Zhao S, Marinelli RJ, et al. Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes. Am J Pathol, 2007; 170(4): 1362-1369.
8. Shimada H, Takeda A, Nabeya Y, et al. Clinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinoma. Cancer, 2001; 92(3): 663-668.
9. Cox G, Jones JL, Walker RA, et al. Angiogenesis and non-small cell lung cancer. Lung Cancer, 2000; 27(2): 81-100.
10. Arora N, Masood R, Zheng T, et al. Vascular endothelial growth factor chimeric toxin is highly active against endothelial cells. Cancer Res, 1999; 59(1): 183-188.
11. Ganjoo KN, Moore AM, Orazi A, et al. The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma, a retrospective study of 97 patients. J Cancer Res Clin Oncol, 2008; 134(3): 381-387.
12. Portlock C. Anti-angiogenesis and diffuse large B-cell lymphoma: a new treatment opportunity? Leuk Lymphoma, 2006; 47 (6): 961-962.